Project Details
Description
A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Dose-Comparison Study to Determine the Efficacy and Safety of BG00012 in Subjects with Relapsing-Remitting
Status | Finished |
---|---|
Effective start/end date | 8/23/07 → 6/30/12 |
Funding
- PRA HEALTH SCIENCES
- BIOGEN INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.